MENU
+Compare
XENE
Stock ticker: NASDAQ
AS OF
Apr 23 closing price
Price
$37.59
Change
+$0.86 (+2.34%)
Capitalization
2.81B

XENE Xenon Pharmaceuticals Forecast, Technical & Fundamental Analysis

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders... Show more

Industry: #Biotechnology
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for XENE with price predictions
Apr 23, 2025

XENE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for XENE turned positive on April 14, 2025. Looking at past instances where XENE's MACD turned positive, the stock continued to rise in of 56 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where XENE's RSI Oscillator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 15, 2025. You may want to consider a long position or call options on XENE as a result. In of 108 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

XENE moved above its 50-day moving average on April 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XENE advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

XENE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XENE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for XENE entered a downward trend on April 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XENE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.724) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.992).

View a ticker or compare two or three
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XENE is expected to report earnings to rise 8.79% to -91 cents per share on May 13

Xenon Pharmaceuticals XENE Stock Earnings Reports
Q1'25
Est.
$-0.91
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.01
Q2'24
Missed
by $0.05
Q1'24
Beat
by $0.04
The last earnings report on February 27 showed earnings per share of -83 cents, beating the estimate of -85 cents. With 701.87K shares outstanding, the current market capitalization sits at 2.81B.
A.I. Advisor
published General Information

General Information

a provider of drug discovery and development services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
200-3650 Gilmore Way
Phone
+1 604 484-3300
Employees
259
Web
https://www.xenon-pharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRSIX10.15N/A
N/A
Bridgeway Ultra-Small Company Market
CWIAX61.03N/A
N/A
American Funds Capital World Gr&Inc 529A
EIIFX11.05N/A
N/A
Eaton Vance Balanced I
JOHIX23.18N/A
N/A
JOHCM International Select Institutional
RGFTX9.74N/A
N/A
Russell Inv Global Infrastructure M

XENE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XENE has been loosely correlated with IDYA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if XENE jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XENE
1D Price
Change %
XENE100%
+2.23%
IDYA - XENE
53%
Loosely correlated
+0.91%
KYMR - XENE
52%
Loosely correlated
+6.56%
CRNX - XENE
51%
Loosely correlated
+3.55%
ATXS - XENE
50%
Loosely correlated
+12.55%
RCKT - XENE
50%
Loosely correlated
+2.44%
More